INOVIO PHARMACEUTICALS INC - COM NEW (INO)

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM NEW
Total 13F shares
11,477,641
Share change
+11,471,508
Total reported value
$124,029,292
Put/Call ratio
388%
Price per share
$10.81
Number of holders
73
Value change
+$123,963,291
Number of buys
71

Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q2 2014

As of 30 Jun 2014, INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,477,641 shares. The largest 10 holders included State Street Corp, VANGUARD GROUP INC, BlackRock Fund Advisors, MORGAN STANLEY, BlackRock Institutional Trust Company, N.A., TIAA CREF INVESTMENT MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, TEACHERS ADVISORS INC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.